Search -

Displaying 21 - 40 of 41

Sort: Relevancy | Date

News Conference News TVT 2020

Stroke in TAVR: Full Impact of Embolic Devices, Anticoagulants, Technique Remain Unclear

Todd Neale

June 25, 2020

News Conference News TVT 2019

What’s The Future For Treating Mitral Valve Disease: Repair, Replace, or Combination Approaches?

Michael O'Riordan

June 14, 2019

Presentation TVT 2019

Prevention of Cardiac Maternal Mortality in the Developing World: Screening Pregnant Women in Hyderabad, India for Structural Heart Disease

Presenter: Amisha Patel

June 14, 2019

Presentation TVT 2019

Operator and Institutional Requirements for PFO Closure for Secondary Prevention of Paradoxical Embolic Stroke

Presenter: Zahid Amin

June 14, 2019

Presentation TVT 2019

Practicalities of Shared Decision-Making for Stroke Prevention: Relevance to LAA Occlusion and PFO Closure

Presenter: Megan Coylewright

June 14, 2019

Presentation TVT 2019

PFO Closure for Secondary Prevention of Paradoxical Embolic Stroke: Randomized Trial Synthesis

Presenter: Fabian Nietlispach

June 14, 2019

Presentation TVT 2019

Prevention and Management of Bioprosthetic Valve Thrombosis

Presenter: Raj Makkar

June 13, 2019

Presentation TVT 2017

A Randomized Trial of Cerebral Embolic Protection in Patients Undergoing Surgical Aortic Valve Replacement (SAVR)

Presenter: Alexandra J. Lansky, Nicolas M. Van Mieghem, Michael J. Mack

June 15, 2017

Presentation TVT 2017

A Description of the U.S. REFLECT Randomized Clinical Trial

Presenter: Jeffrey W. Moses

June 15, 2017

Presentation TVT 2017

Device Design Features and Findings From EU Clinical Trials

Presenter: Joachim Schofer

June 15, 2017

Presentation TVT 2017

A Propensity Score Analysis of Matched TAVR Patients With and Without Cerebral Protection

Presenter: Jochen Wöhrle

June 15, 2017

Presentation TVT 2017

Device Design Features and Findings From the Meta-Analysis of Three Randomized Clinical Trials

Presenter: Axel Linke

June 15, 2017

Presentation TVT 2017

The Compelling Saga of Strokes After TAVR (and SAVR): Diagnosis Considerations and Key Messages From NeuroARC

Presenter: Alexandra J. Lansky, Nicolas M. Van Mieghem

June 15, 2017

Presentation TVT 2015

Annulus Rupture During TAVR: Prevention and Management

Presenter: Marco Barbanti

June 05, 2015

Presentation TVT 2015

Coronary Obstruction During TAVR: Prevention and Management

Presenter: Howard C. Herrmann

June 05, 2015

Presentation TVT 2015

Prevention and Management of Conduction Disturbances and Arrhythmias (AF) After TAVR

Presenter: Tamim Nazif

June 05, 2015

Presentation TVT 2015

Coronary Obstruction During Aortic Valve-in-Valve Therapy: Predictors and Prevention

Presenter: Vinayak Bapat, Danny Dvir, Raj Makkar

June 05, 2015

Presentation TVT 2014

PVR Highlights- Etiologies, Diagnosis, Incidence, Clinical Impact, Prevention, and Treatment

Presenter: Susheel Kodali

June 06, 2014

Presentation TVT 2013

Comparison of CT and 3-D TEE for THV Sizing and Prevention of PVL

Presenter: Raj Makkar

June 13, 2013

Presentation TVT 2012

The Evolving Standard of Care: Oral Antithrombotic Agents for Stroke Prevention in Atrial Fibrillation

Presenter: Gregg Stone

June 05, 2012

Advertisement

Stroke in TAVR: Full Impact of Embolic Devices, Anticoagulants, Technique Remain Unclear

What’s The Future For Treating Mitral Valve Disease: Repair, Replace, or Combination Approaches?

Prevention of Cardiac Maternal Mortality in the Developing World: Screening Pregnant Women in Hyderabad, India for Structural Heart Disease

Operator and Institutional Requirements for PFO Closure for Secondary Prevention of Paradoxical Embolic Stroke

Practicalities of Shared Decision-Making for Stroke Prevention: Relevance to LAA Occlusion and PFO Closure

PFO Closure for Secondary Prevention of Paradoxical Embolic Stroke: Randomized Trial Synthesis

Prevention and Management of Bioprosthetic Valve Thrombosis

A Randomized Trial of Cerebral Embolic Protection in Patients Undergoing Surgical Aortic Valve Replacement (SAVR)

A Description of the U.S. REFLECT Randomized Clinical Trial

Device Design Features and Findings From EU Clinical Trials

A Propensity Score Analysis of Matched TAVR Patients With and Without Cerebral Protection

Device Design Features and Findings From the Meta-Analysis of Three Randomized Clinical Trials

The Compelling Saga of Strokes After TAVR (and SAVR): Diagnosis Considerations and Key Messages From NeuroARC

Annulus Rupture During TAVR: Prevention and Management

Coronary Obstruction During TAVR: Prevention and Management

Prevention and Management of Conduction Disturbances and Arrhythmias (AF) After TAVR

Coronary Obstruction During Aortic Valve-in-Valve Therapy: Predictors and Prevention

PVR Highlights- Etiologies, Diagnosis, Incidence, Clinical Impact, Prevention, and Treatment

Comparison of CT and 3-D TEE for THV Sizing and Prevention of PVL

The Evolving Standard of Care: Oral Antithrombotic Agents for Stroke Prevention in Atrial Fibrillation

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content